CommercialPrior AuthMedium impact
State and School Employees' Health Insurance Plan - Interleukin-1 Inhibitors (Ilaris)
Blue Cross & Blue Shield of Mississippi·MS · Rheumatology, Allergy & Immunology, Pediatrics +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
New prior authorization policy for Ilaris (canakinumab) under Mississippi State and School Employees' Health Plan establishes strict medical necessity criteria for various inflammatory conditions including CAPS, TRAPS, HIDS/MKD, FMF, and Still's Disease. Initial approvals require specialist prescriber and specific clinical documentation with 6-month approval periods.
Action Required
Immediately: Update prior authorization procedures for Ilaris (canakinumab) billing. Ensure specialist prescribers document all required clinical criteria including genetic testing, inflammatory markers, and specific symptoms based on diagnosis. Verify patients meet age requirements and have tried conventional therapies where applicable. Submit detailed clinical documentation for 6-month initial approval or 12-month renewal approval through BCBSMS review process.